Ethyl Icosapentate Capsules 300mg (Epadel® / エパデールカプセル300)

JPY ¥2,700

Japanese EPA preparation (Ethyl Icosapentate 300mg). Oral capsules for treatment of arteriosclerosis obliterans and hyperlipidemia. 100 capsules (10 capsules x 10). Mfd. by Mochida Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥2,484
10 - 19 12% JPY ¥2,376
20 + 18% JPY ¥2,214
SKU: EPA-300-CAP Category:

Description

Product Overview / 商品概要

Epadel Capsules 300 (エパデールカプセル300)
Generic: Ethyl Icosapentate / イコサペント酸エチル
Therapeutic Category: EPA (Eicosapentaenoic Acid) Preparation / EPA製剤
Manufactured by: Mochida Pharmaceutical Co., Ltd. / 持田製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Ethyl Icosapentate (JP) 300mg per capsule / 1カプセル中 日局 イコサペント酸エチル 300mg
Additives: Contents: Tocopherol. Capsule shell: Gelatin, Succinylated gelatin, Concentrated glycerin, Ethyl parahydroxybenzoate, Propyl parahydroxybenzoate / 内容物:トコフェロール カプセル:ゼラチン、コハク化ゼラチン、濃グリセリン、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル
Appearance: Pale yellow, transparent soft capsule; approximately 18mm in length; identification code MO207 (printed on PTP sheet)
外観: 淡黄色透明(軟カプセル剤)、外形約18mm、識別コード MO207(PTPに表示)

Indications / 効能効果

EN: Improvement of ulcers, pain, and cold sensation associated with arteriosclerosis obliterans; Hyperlipidemia
JA: ○閉塞性動脈硬化症に伴う潰瘍、疼痛および冷感の改善 ○高脂血症

Dosage and Administration / 用法用量

EN: For arteriosclerosis obliterans: Usual adult dose is 600mg (2 capsules) three times daily, administered orally immediately after each meal. Dose may be adjusted according to age and symptoms. For hyperlipidemia: Usual adult dose is 900mg (3 capsules) twice daily or 600mg (2 capsules) three times daily, administered orally immediately after meals. In cases with marked hypertriglyceridemia, dose may be increased up to 900mg (3 capsules) three times daily.
JA: 〈閉塞性動脈硬化症に伴う潰瘍、疼痛および冷感の改善〉イコサペント酸エチルとして、通常、成人1回600mg(2カプセル)を1日3回、毎食直後に経口投与する。なお、年齢、症状により、適宜増減する。〈高脂血症〉イコサペント酸エチルとして、通常、成人1回900mg(3カプセル)を1日2回又は1回600mg(2カプセル)を1日3回、食直後に経口投与する。ただし、トリグリセリドの異常を呈する場合には、その程度により、1回900mg(3カプセル)、1日3回まで増量できる。

Contraindications / 禁忌

EN: 2.1 Patients with active bleeding (e.g., hemophilia, capillary fragility, gastrointestinal ulcer, urinary tract bleeding, hemoptysis, vitreous hemorrhage). 2.2 Patients receiving mifepristone/misoprostol.
JA: 2.1 出血している患者(血友病、毛細血管脆弱症、消化管潰瘍、尿路出血、喀血、硝子体出血等) 2.2 ミフェプリストン・ミソプロストールを投与中の患者

Regulatory Information / 規制情報

Approval No.: 20200AMZ00642000
Sales Started: June 1990 / 1990年6月
Classification Code: 873399 / 872189
Storage: Store at room temperature / 室温保存
Shelf Life: 3.5 years / 3.5年

Packaging / 包装

Main Package (for sale): 100 capsules (10 capsules x 10) / 100カプセル(10カプセル×10)
Other Available Packages (by special order): PTP: 100 capsules (10 capsules x 10), 500 capsules (10 capsules x 50), 1,000 capsules (10 capsules x 100), 1,050 capsules (21 capsules x 50)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Ethyl Icosapentate Capsules 300mg (Epadel® / エパデールカプセル300)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Ethyl Icosapentate Capsules 300mg (Epadel®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.